GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » EV-to-Revenue

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) EV-to-Revenue : (As of Jun. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Arbor Rapha Capital Bioholdings I's enterprise value is $260.02 Mil. Arbor Rapha Capital Bioholdings I's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil. Therefore, Arbor Rapha Capital Bioholdings I's EV-to-Revenue for today is .

The historical rank and industry rank for Arbor Rapha Capital Bioholdings I's EV-to-Revenue or its related term are showing as below:

ARCK's EV-to-Revenue is not ranked *
in the Diversified Financial Services industry.
Industry Median: 4.23
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-14), Arbor Rapha Capital Bioholdings I's stock price is $11.90. Arbor Rapha Capital Bioholdings I's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00. Therefore, Arbor Rapha Capital Bioholdings I's PS Ratio for today is .


Arbor Rapha Capital Bioholdings I EV-to-Revenue Historical Data

The historical data trend for Arbor Rapha Capital Bioholdings I's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbor Rapha Capital Bioholdings I EV-to-Revenue Chart

Arbor Rapha Capital Bioholdings I Annual Data
Trend Dec21
EV-to-Revenue
-

Arbor Rapha Capital Bioholdings I Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EV-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Arbor Rapha Capital Bioholdings I's EV-to-Revenue

For the Shell Companies subindustry, Arbor Rapha Capital Bioholdings I's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arbor Rapha Capital Bioholdings I's EV-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Arbor Rapha Capital Bioholdings I's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Arbor Rapha Capital Bioholdings I's EV-to-Revenue falls into.



Arbor Rapha Capital Bioholdings I EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Arbor Rapha Capital Bioholdings I's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=260.023/0
=

Arbor Rapha Capital Bioholdings I's current Enterprise Value is $260.02 Mil.
Arbor Rapha Capital Bioholdings I's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arbor Rapha Capital Bioholdings I  (NAS:ARCK) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Arbor Rapha Capital Bioholdings I's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=11.90/0
=

Arbor Rapha Capital Bioholdings I's share price for today is $11.90.
Arbor Rapha Capital Bioholdings I's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arbor Rapha Capital Bioholdings I EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Traded in Other Exchanges
N/A
Address
333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553
Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Ralph Mack director 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin director, officer: Chief Strategy Officer C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio officer: Chief Financial Officer C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone officer: Treasurer C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly officer: Secretary & Vice President C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker director C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin director C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines